Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

  • There is currently no data for CRL

Acquisition

16 Feb 2016 17:10

RNS Number : 2543P
Creightons PLC
16 February 2016
 

 

For Immediate Release 16 February 2016

 

Creightons plc (the "Company", "Creightons" or "Cplc")

 

Acquisition of certain assets of Broad Oak Toiletries Ltd (in Administration) ("BOT")

 

The Company announces that today Potter & Moore (Devon) Ltd ("PMD"), a wholly-owned subsidiary of Creightons plc, has purchased certain assets of Broad Oak Toiletries Ltd (in Administration) to include all unencumbered plant and equipment but excluding assets subject to HP, all stock and the IP including formulations, manufacturing methods, manufacturing and component specifications.

BOT is a private UK company which operated in a similar area of the toiletries contract manufacturing market to the Company, mainly supplying small batch high value products to its customers. It is proposed that the assets being acquired will be used as part of the Company's operations in that market to increase capacity and the range of products available to customers. 

 

The last available audited accounts for BOT for the year ended 31 January 2015 reported a Loss before tax of £770,000 attributable to the assets subject to this purchase although this was based on Turnover of £19.081million. Given the current condition of BOT's business, the Company believes it can achieve sales of £3.2million for the year to 31 January 2017 thus making a positive contribution to the results of the Group. The Company anticipates that the wider range of production capabilities together with its existing excellent reputation for customer service will enable the Company to re-build relationships with BOT's customers and generate increased sales for the enlarged operation.

 

The total consideration for the purchase is £600,002 which will be paid in cash from the current reserves of the Company.

 

The gross value of the consideration amounting to £600,002 of the assets acquired will be allocated as follows in the consolidated accounts of Company:

- Fixed assets £540,000

- IP £10,002

- Stock £50,000

Total £600,002

 

Stock valued at £168,000 will be acquired by PMD for £50,000 and therefore the Company will account for this as a debit to Gross Assets but then a credit to goodwill as negative goodwill of £118,000. This is because PMD will acquire it as part of the transaction for £50,000 and may only be able to realise value from it if existing contracts are retained.

 

The Company anticipates that the additional assets will enable it to increase consolidated group sales by some £3.2million in the first full year through additional capacity, supplying new customers and offering existing customers products previously manufactured by BOT.

 

Neither PMD nor the Company has agreed to take on any employees from BOT, and the Company understands that all were made redundant before the acquisition of these assets. 

 

Speaking after the transaction had been completed, the Company's Chairman, Mr William McIlroy said: "We are very excited by this acquisition which complements the Company's existing production capabilities which we are confident will add to both the Company's sales and profits by enabling us to produce and supply new product ranges such as Soap, Candles and Powder products to an enlarged customer base who will benefit from our superior supply chain management."

 

End

 

For further information, contact Mr Paul Forster, MD UK Operations or Mr Nick O'Shea, Company Secretary on 01733 281000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQDQLFFQLFBBBD
Date   Source Headline
7th Mar 20247:00 amRNSDirectorate Change
4th Dec 20237:00 amRNSHalf-year Report
27th Nov 20237:00 amRNSDirectorate Change
25th Sep 202311:50 amRNSDirector/PDMR Shareholding
15th Sep 20235:24 pmRNSBlock listing Interim Review
14th Sep 20239:52 amRNSResult of AGM
1st Sep 20235:17 pmRNSDirector/PDMR Shareholding
1st Sep 20235:05 pmRNSDirector/PDMR Shareholding
25th Aug 20233:32 pmRNSDirector/PDMR Shareholding
31st Jul 20232:53 pmRNSReplacement: Director/PDMR Shareholding
24th Jul 202311:54 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSAudited preliminary results
31st Mar 202310:49 amRNSTotal Voting Rights
17th Mar 20237:00 amRNSBlock listing Interim Review
16th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Jan 20232:05 pmRNSSecond Price Monitoring Extn
27th Jan 20232:00 pmRNSPrice Monitoring Extension
12th Jan 20232:05 pmRNSSecond Price Monitoring Extn
12th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Dec 202211:05 amRNSSecond Price Monitoring Extn
30th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20224:40 pmRNSSecond Price Monitoring Extn
20th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSHalf-year Report
29th Nov 20224:41 pmRNSSecond Price Monitoring Extn
29th Nov 20224:36 pmRNSPrice Monitoring Extension
25th Nov 20227:00 amRNSInterim Results 2022 - announcement, presentations
27th Sep 20227:00 amRNSUpdate on Emma Hardie, Trading in own shares & TVR
20th Sep 20229:22 amRNSBlock Listing Update
24th Aug 20221:01 pmRNSResult of AGM
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
12th Jul 20227:00 amRNSResults for year to end 31 March 2022
11th Jul 20227:00 amRNSPreliminary Results, investor/analyst presentation
4th Jul 20224:42 pmRNSTotal Voting Rights
7th Jun 20223:28 pmRNSTotal Voting Rights
3rd May 20226:09 pmRNSTotal Voting Rights
12th Apr 20224:33 pmRNSDirector/PDMR Dealing, Total Voting Rights
21st Mar 202211:37 amRNSBlock listing Interim Review
7th Mar 20229:59 amRNSTotal Voting Rights
14th Jan 20222:58 pmRNSTotal Voting Rights
30th Dec 20217:00 amRNSHalf-year Report
15th Dec 20212:52 pmRNSNotice of Interim Results & Investors Presentation
6th Dec 20215:38 pmRNSTotal Voting Rights
25th Nov 20216:18 pmRNSDirector/PDMR Shareholding and Total Voting Rights
23rd Nov 20214:49 pmRNSDirector/PDMR Shareholding
18th Nov 202111:55 amRNSDirector/PDMR Shareholding
17th Nov 20211:58 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSDirector/PDMR Shareholding
29th Oct 20215:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.